Authors:
DECKERT J
NOTHEN MM
ALBUS M
FRANZEK E
RIETSCHEL M
REN HZ
STILES GL
KNAPP M
WEIGELT B
MAIER W
BECKMANN H
PROPPING P
Citation: J. Deckert et al., ADENOSINE A(1) RECEPTOR AND BIPOLAR AFFECTIVE-DISORDER - SYSTEMATIC SCREENING OF THE GENE AND ASSOCIATION STUDIES, American journal of medical genetics, 81(1), 1998, pp. 18-23
Citation: Hz. Ren et Gl. Stiles, A SINGLE-STRANDED-DNA BINDING-SITE IN THE HUMAN A(1) ADENOSINE RECEPTOR GENE PROMOTER, Molecular pharmacology, 53(1), 1998, pp. 43-51
Authors:
JACOBSON KA
PARK KS
JIANG JL
KIM YC
OLAH ME
STILES GL
JI XD
Citation: Ka. Jacobson et al., PHARMACOLOGICAL CHARACTERIZATION OF NOVEL A(3) ADENOSINE RECEPTOR-SELECTIVE ANTAGONISTS, Neuropharmacology, 36(9), 1997, pp. 1157-1165
Citation: Tm. Palmer et al., INDUCTION OF MULTIPLE EFFECTS ON ADENYLYL-CYCLASE REGULATION BY CHRONIC ACTIVATION OF THE HUMAN A(3) ADENOSINE RECEPTOR, Molecular pharmacology, 52(4), 1997, pp. 632-640
Citation: Tm. Palmer et Gl. Stiles, IDENTIFICATION OF AN A(2) ADENOSINE RECEPTOR DOMAIN SPECIFICALLY RESPONSIBLE FOR MEDIATING SHORT-TERM DESENSITIZATION, Biochemistry, 36(4), 1997, pp. 832-838
Authors:
VANRHEE AM
JIANG JL
MELMAN N
OLAH ME
STILES GL
JACOBSON KA
Citation: Am. Vanrhee et al., INTERACTION OF 1,4-DIHYDROPYRIDINE AND PYRIDINE-DERIVATIVES WITH ADENOSINE RECEPTORS - SELECTIVITY FOR A(3) RECEPTORS, Journal of medicinal chemistry, 39(15), 1996, pp. 2980-2989
Citation: Tm. Palmer et al., MOLECULAR-BASIS FOR SUBTYPE-SPECIFIC DESENSITIZATION OF INHIBITORY MOLECULAR ADENOSINE RECEPTORS - ANALYSIS OF A CHIMERIC A(1)-A(3) ADENOSINE RECEPTOR, The Journal of biological chemistry, 271(25), 1996, pp. 15272-15278
Citation: Me. Olah et Gl. Stiles, IDENTIFICATION OF A2A ADENOSINE RECEPTOR REGIONS INVOLVED IN ADENYLYL-CYCLASE STIMULATION, Circulation, 94(8), 1996, pp. 1680-1680
Citation: Me. Olah et Gl. Stiles, ADENOSINE RECEPTOR SUBTYPES - CHARACTERIZATION AND THERAPEUTIC REGULATION, Annual review of pharmacology and toxicology, 35, 1995, pp. 581-606
Authors:
PALMER TM
POUCHER SM
JACOBSON KA
STILES GL
Citation: Tm. Palmer et al., I-125 ZOLO(2,3-A)(1,3,5)TRIAZIN-5-YL-AMINO]ETHYL)PHENOL, A HIGH-AFFINITY ANTAGONIST RADIOLIGAND SELECTIVE FOR THE A(2A) ADENOSINE RECEPTOR, Molecular pharmacology, 48(6), 1995, pp. 970-974
Citation: Hz. Ren et Gl. Stiles, SEPARATE PROMOTERS IN THE HUMAN A(1) ADENOSINE RECEPTOR GENE DIRECT THE SYNTHESIS OF DISTINCT MESSENGER-RNAS THAT REGULATE RECEPTOR ABUNDANCE, Molecular pharmacology, 48(6), 1995, pp. 975-980
Authors:
SIDDIQI SM
JACOBSON KA
ESKER JL
OLAH ME
JI XD
MELMAN N
TIWARI KN
SECRIST JA
SCHNELLER SW
CRISTALLI G
STILES GL
JOHNSON CR
IJZERMAN AP
Citation: Sm. Siddiqi et al., SEARCH FOR NEW PURINE-MODIFIED AND RIBOSE-MODIFIED ADENOSINE-ANALOGS AS SELECTIVE AGONISTS AND ANTAGONISTS AT ADENOSINE RECEPTORS, Journal of medicinal chemistry, 38(7), 1995, pp. 1174-1188
Authors:
JACOBSON KA
SIDDIQI SM
OLAH ME
JI XD
MELMAN N
BELLAMKONDA K
MESHULAM Y
STILES GL
KIM HO
Citation: Ka. Jacobson et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF 9-ALKYLADENINE AND RIBOSE-MODIFIED ADENOSINE DERIVATIVES AT RAT A(3) ADENOSINE RECEPTORS, Journal of medicinal chemistry, 38(10), 1995, pp. 1720-1735
Citation: Tm. Palmer et al., AGONIST-DEPENDENT PHOSPHORYLATION AND DESENSITIZATION OF THE RAT A(3)ADENOSINE RECEPTOR - EVIDENCE FOR A G-PROTEIN-COUPLED RECEPTOR KINASE-MEDIATED MECHANISM, The Journal of biological chemistry, 270(49), 1995, pp. 29607-29613
Citation: Tm. Palmer et al., DIFFERENTIAL INTERACTION WITH AND REGULATION OF MULTIPLE G-PROTEINS BY THE RAT A(3) ADENOSINE RECEPTOR, The Journal of biological chemistry, 270(28), 1995, pp. 16895-16902
Authors:
DECKERT J
NOTHEN MM
BRYANT SP
REN HZ
WOLF HK
STILES GL
SPURR NK
PROPPING P
Citation: J. Deckert et al., HUMAN ADENOSINE A(1) RECEPTOR GENE - SYSTEMATIC SCREENING FOR DNA-SEQUENCE VARIATION AND LINKAGE MAPPING ON CHROMOSOME 1Q31-32.1 USING A SILENT POLYMORPHISM IN THE CODING REGION, Biochemical and biophysical research communications, 214(2), 1995, pp. 614-621
Citation: Me. Olah et al., ADENOSINE RECEPTORS - PROTEIN AND GENE STRUCTURE, Archives internationales de pharmacodynamie et de therapie, 329(1), 1995, pp. 135-150